Anchiano Therapeutics Ltd.

SEC CIK 0001534248

CIK #1534248

The following is an index of Security and Exchange Commission registration information for Anchiano Therapeutics Ltd.. This page includes all SEC filing details as well as a list of any documents (S-1, Prospecuts, Current Reports, 8-K, 10K, Annual Reports) registered by Anchiano Therapeutics Ltd..
Latest Edgar Filing Status
Updated2019-02-08
SIC Code2834
Reporting File Number001-38807
Mailing Address1/3 HIGH-TECH VILLAGE GIVAT RAM, P.0. BOX 39264 JERUSALEM, ISRAEL 9139102
StateISRAEL
Contact Phone972-2-5486555
Fiscal Year End Date1231

Documents Filed
Anchiano Therapeutics Ltd. SEC Filings RSS Feed

Title
Date
Form
2019-08-13 17:15:33-04:00
6-K
2019-08-06 09:15:02-04:00
6-K
2019-07-22 17:17:45-04:00
S-8
2019-07-08 07:30:20-04:00
6-K
2019-06-26 21:15:41-04:00
SC 13D/A [Amend]
2019-06-26 09:47:15-04:00
SC 13G/A [Amend]
2019-06-18 08:30:38-04:00
6-K
2019-06-11 07:54:27-04:00
SC 13G
2019-05-28 17:26:35-04:00
6-K
2019-05-22 09:00:13-04:00
6-K
2019-04-24 17:19:45-04:00
20-F/A [Amend]
2019-03-25 16:15:38-04:00
20-F
2019-03-14 07:00:40-04:00
6-K
2019-03-12 16:15:52-04:00
6-K
2019-02-25 16:34:08-05:00
SC 13D/A [Amend]
2019-02-21 16:58:33-05:00
SC 13D
2019-02-14 16:40:31-05:00
6-K
2019-02-13 08:20:37-05:00
Prospectus [Rule 424(b)(4)]
2019-02-12 09:15:19-05:00
6-K
2019-02-08 10:16:12-05:00
Confidential treatment order
2019-02-12 00:15:16-05:00
Notice of Effectiveness
2019-02-11 11:39:59-05:00
2019-02-11 10:59:47-05:00
SEC-generated letter
2019-02-11 10:02:45-05:00
Correspondence
2019-02-11 09:52:44-05:00
F-1/A [Amend]
2019-02-08 17:09:10-05:00
8-A12B
2019-02-07 17:34:36-05:00
F-1/A [Amend]
2019-02-07 17:39:18-05:00
Correspondence
2019-02-07 17:38:52-05:00
Correspondence
2019-02-07 17:38:15-05:00
Correspondence
2019-02-05 17:30:28-05:00
F-1/A [Amend]
2019-02-04 15:44:39-05:00
SEC-generated letter
2019-01-30 20:20:23-05:00
F-1/A [Amend]
2019-01-07 17:14:01-05:00
Correspondence
2019-01-07 17:11:14-05:00
F-1
2018-12-11 11:21:37-05:00
SEC-generated letter
2018-11-26 19:55:07-05:00
Draft Registration Statement
2018-11-26 20:15:12-05:00
DRSLTR [Cover]
2018-10-25 17:08:47-04:00
SEC-generated letter
2018-09-28 12:55:27-04:00
Draft Registration Statement
2015-11-03 17:11:02-05:00
Draft Registration Statement
2015-09-22 09:25:35-04:00
Draft Registration Statement
2013-04-23 11:56:14-04:00
20-F
2013-01-08 08:52:36-05:00
SC 13D/A [Amend]
2013-01-02 06:13:59-05:00
15-15D
2012-12-27 12:05:29-05:00
S-8 POS
2012-12-26 15:46:48-05:00
6-K
2012-12-19 00:15:11-05:00
Notice of Effectiveness
2012-12-17 14:33:57-05:00
6-K
2012-12-17 12:26:09-05:00
SC 13D/A [Amend]
2012-12-17 11:30:34-05:00
POS AM
2012-11-27 14:26:52-05:00
6-K
2012-11-14 13:08:15-05:00
6-K
2012-11-05 06:01:50-05:00
6-K
2012-10-22 15:25:27-04:00
6-K
2012-10-02 06:46:08-04:00
6-K
2012-10-01 17:20:29-04:00
6-K
2012-09-04 06:02:55-04:00
6-K
2012-08-20 06:02:38-04:00
6-K
2012-08-16 10:01:44-04:00
SC 13D
2012-08-15 15:10:56-04:00
S-8
2012-08-13 11:29:39-04:00
6-K
2012-08-09 07:54:52-04:00
6-K
2012-07-23 11:03:13-04:00
6-K
2012-06-08 00:15:13-04:00
Notice of Effectiveness
2012-06-07 14:40:24-04:00
Prospectus [Rule 424(b)(3)]
2012-06-05 10:58:57-04:00
F-4/A [Amend]
2012-05-29 09:25:01-04:00
F-4/A [Amend]
2012-01-24 11:50:25-05:00
F-4
2011-11-07 17:09:39-05:00
425

Related SEC Filings - Anchiano Therapeutics 🔎

Anchiano Therapeutics Ltd. of ISRAEL0001534248
Anchiano Therapeutics Ltd./ADR0001762418

© 2019 SEC.report
SEC CFR Title 17 of the Code of Federal Regulations.